STO:ODI
ODI Pharma AB · STO · Healthcare · SEK · FY for 2026
Figures on this page computed 2026-11-08 13:20 UTC
Last close
n/aSEK
Market data
14.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- computed
- Computed from the filing for 2026
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
6.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
13.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- computed
Safety is the furthest below its sector's middle: 0.46 against 0.63 on the market's range.
- Growth133.8%89 of 100, above its sector
- Returns on capital83.7%99 of 100, above its sector
- Margins31.2%60 of 100, above its sector
- Price14.4x47 of 100, above its sector
- Safety1.8146 of 100, below its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Then and now
lens 3 of 9| Fact | 2019 | 2026 | Change |
|---|---|---|---|
| Sales | n/a | 32,915,945 | n/a |
| Profit | -3,632,755 | 1,987,659 | +155% |
| Free cash flow | -3,365,426 | 4,576,073 | +236% |
| Debt | n/a | n/a | n/a |
| Shares in issue | 15,220,000 | 18,330,419 | +20.4% |
The same five facts for 2019 and 2026, each read from the year's own filing.
The same five facts for 2019 and 2026, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2019
Sales, 2019n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- SEK
Sales, 202632,915,945Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK
Profit, 2019-3,632,755
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- SEK
Profit, 20261,987,659Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK
Free cash flow, 2019-3,365,426
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- SEK
Free cash flow, 20264,576,073Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK
Debt, 2019n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- SEK
Debt, 2026n/aComputed from the filing for 2026
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK
Shares in issue, 201915,220,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2019
- Reported in
- SEK
Shares in issue, 202618,330,419Computed from the filing for 2026
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- SEK